Brand Name only: US SOURCE heat activated Fetal Bovine Serum, from same LOT#.

FedBizOps Synopsis

Title: Brand Name only: US SOURCE heat activated Fetal Bovine Serum, from same LOT#.
Solicitation Number: RFQ1920143

Description:

This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 "Streamlined Procedures for Evaluation and solicitation for commercial Items," as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ1920143 and the solicitation is issued as a Request for Quotes (RFQ).

This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2005_7-16-18 as of 07/30/2018

The North American Industry Classification System (NAICS) code for this procurement is 325414, Biological Product (except Diagnostic) Manufacturing, with a small business size standard of 1250 employees. This is a total small business set aside with brand name requirements. The acquisition is being competed full and open with brand name or equal restriction.

The National Institute of Allergy and Infectious Diseases (NIAID) has a brand name requirement for the following item. These supplies will be used in the NIAID, Laboratory of Infectious Disease (LID).

Place of Performance: NIH, 50 South Dr., Bethesda, MD 20892, United States. FOB: Destination

Brand name Only requirements:

Manufactured by: https://www.omegascientific.com/shop/animal-sera/fetal-bovine-serum-u-s-source-heat-inactivated/

Fetal Bovine Serum, Omega Scientific CAT# FB-12, Quantity of 150, 500ML - US Source and heat activated, all from one LOT#. LOT# will be determined after award.

Additional requirements:
100% Quality Guaranteed in which vendor will replace any unopened bottles at no charge if the customer is not completely satisfied with the quality of the sera.

Delivery charges - An estimation of 6 deliveries as the lab requests from the time of award, with a one-year period of performance. Dates to be determined at time of award.

Storage fees to store serum until it is shipped

Triple 0.1 Micron Filtered, virus screened, and mycoplasma tested.

Only quotes for the specific Omega Scientific CAT# FB-12 and from small businesses will be accepted.

The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. The award will be based on the following; capability to meet the requirements, delivery time, warranty, and price and the best value to the government.

We have used this serum in our current study since the beginning, and due to our protocols, we must maintain consistency and continuity though out the entire study. Since all FBS doesn't support growth of given cells in the same way and work in all systems. We have previously tested specific brands and lot numbers of serum to determine if they will support our specific cells and culture systems. The fetal bovine serum that is being requested is required as it has been tested with our cell lines, primary cells and culture systems to provide sufficient nutrients to support growth. We have determined that this specific FBS works in our culture systems to support cell and virus growth. Other FBS lots and different vendors serum did not support as cell growth that is required to perform our scientific studies and would cause the progress of our current study to be invalid, due the continuity requirements of the protocols.

The following FAR provisions apply to this acquisition:

FAR 52.212-1 Instructions to Offerors Commercial Items (Oct 2014)

FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (Nov 2017)

Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Dec 2014) is updated in your SAM record)
FAR 52.204-7 System for Award Management (July 2013)
FAR 52.203-19 - Prohibition on Requiring Certain Internal Confidentiality Agreements or Statements.

The following FAR contract clauses apply to this acquisition:

FAR 52-212-4 Contract Terms and Conditions Commercial Items (Jan 2017)

FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (Jan 2017)
*The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting.

FAR 52.204-18 Commercial and Government Entity Code Maintenance (Nov 2014)

FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (Dec 2013)

FAR 52.204-13 System for Award Management Maintenance (July 2013)

HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (January 2010)

By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).

Copies of the above-referenced provisions and clauses are available from https://www.acquisition.gov/browsefar
& https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html or, upon request, either by telephone or fax.

Submission shall be received not later than Thursday, August 9th, 2018 by 5:00 p.m. Eastern time

Offers may be mailed, e-mailed to Jesse.weidow@nih.gov
Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f)

All responsible sources may submit an offer that will be considered by this Agency.
Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Jesse Weidow @ Jesse.weidow@nih.gov

.